Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BAYER AG

(BAYN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
04/12/2021 04/13/2021 04/14/2021 04/15/2021 04/16/2021 Date
52.94(c) 52.95(c) 52.9(c) 52.88(c) 54(c) Last
2 426 187 3 148 647 2 522 430 3 072 583 4 958 464 Volume
-0.75% +0.02% -0.09% -0.04% +2.12% Change
More quotes
Financials
Sales 2021 41 001 M 49 120 M 49 120 M
Net income 2021 2 993 M 3 586 M 3 586 M
Net Debt 2021 39 552 M 47 383 M 47 383 M
P/E ratio 2021 17,0x
Yield 2021 3,70%
Sales 2022 42 451 M 50 856 M 50 856 M
Net income 2022 4 386 M 5 254 M 5 254 M
Net Debt 2022 35 545 M 42 583 M 42 583 M
P/E ratio 2022 13,2x
Yield 2022 3,94%
Capitalization 53 051 M 63 549 M 63 555 M
EV / Sales 2021 2,26x
EV / Sales 2022 2,09x
Nbr of Employees 95 955
Free-Float 100,0%
More Financials
Company
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Sales are distributed by product family as follows: - agrochemicals (45.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (41.2%) : intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc. ; - OTC... 
Sector
Pharmaceuticals
Calendar
04/27 | 04:00amShareholder meeting
More about the company
Notations Surperformance© of Bayer AG
Trading Rating : Investor Rating :
More Ratings
All news about BAYER AG
04/15CUREVAC N  : On Track to Provide Data for Conditional Approval of COVID-19 Vacci..
MT
04/15Big business seeks unified, market-based approaches ahead of climate summit
RE
04/15PRESS RELEASE : CureVac Announces Financial -2-
DJ
04/15PRESS RELEASE : CureVac Announces Financial Results and Business Updates for the..
DJ
04/15PRESS RELEASE  : Tele Columbus AG: Wohnungsgenossenschaft 'Glückauf' chooses Sma..
DJ
04/15EXCLUSIVE : New zinc-fortified wheat set for global expansion to combat malnutri..
RE
04/14SHANGHAI STOCK EXCHANGE B SHARES IND : China Opens Innovative Medicines, Medical..
MT
04/14BAYER  : and SVG Ventures | THRIVE partner to tackle agriculture's grand challen..
PU
04/14PRESS RELEASE : Tele Columbus AG: Successful completion of the takeover offer fo..
DJ
04/13PRESS RELEASE : Evotec launches 'beLAB2122', translating academic innovation fro..
DJ
04/12BAYER  : Investigational Blood Cancer Combo Cuts Risk of Death in Phase 3 Trial
MT
04/10BAYER  : Combination of copanlisib and rituximab significantly increases progres..
PU
04/09BASF  : Bayer, Corteva in 'two-dog battle' over U.S. soy market
RE
04/09PRESS RELEASE : Evotec and Exscientia announce start of human clinical trials of..
DJ
04/06Bayer Restructuring U.S. Corporate Affairs
DJ
More news
News in other languages on BAYER AG
03:38aUnternehmen wollen Impfaktion in Deutschland beschleunigen
04/16DGAP-HV  : Aareal Bank AG: Bekanntmachung der -2-
04/15CORONA-BLOG/Portugal lockert Corona-Auflagen weiter
04/15CORONA-BLOG/Israel hebt Maskenpflicht im Freien auf
04/15CORONA-BLOG/Frankreich zählt mehr als 100.000 Todesfälle wegen Covid-19
More news
Analyst Recommendations on BAYER AG
More recommendations
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 62,78 €
Last Close Price 54,00 €
Spread / Highest target 57,4%
Spread / Average Target 16,3%
Spread / Lowest Target -50,1%
EPS Revisions
Managers and Directors
NameTitle
Werner Baumann Chairman-Management Board
Wolfgang U. Nickl Chief Financial Officer
Norbert Winkeljohann Chairman-Supervisory Board
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG12.14%63 549
JOHNSON & JOHNSON3.09%422 260
ROCHE HOLDING AG0.16%289 178
PFIZER INC.2.15%209 739
NOVARTIS AG-3.73%197 072
MERCK & CO., INC.-5.29%194 049